DAVID S. GRAYZEL - 01 Apr 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Director
Signature
/s/ Ommer Chohan, Attorney-in-Fact
Issuer symbol
QTTB
Transactions as of
01 Apr 2024
Transactions value $
$34,476
Form type
4
Filing time
14 Aug 2024, 16:05:06 UTC
Previous filing
27 Mar 2024
Next filing
11 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTTB Stock Option (Right to Buy) Award $34,475 +2,569 $13.42 2,569 01 Apr 2024 Common Stock 2,569 $18 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive equity in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The shares underlying this option shall vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.
F3 This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.